Kaiqi Liu

ORCID: 0000-0002-2120-5262 · 1 paper in corpus · active 2022

Study types

  • article 1
article 2022
·doi:10.1182/blood-2022-164675

INTRODUCTION Despite the efficacy and outcome of AML patients increases in recent decades, the rate of relapse is still high, especially in the patients who are ineligible for allo-HSCT. How to prevent relapse is still a major therapeutic c…